Clinical trials show impressive results: Semaglutide users lost an average of 1517 % of their body weight over 68 weeks
Trmper A, Trmper K, Trusheim H, Arnold R, Gke B, Hrsch D
The UK and EU product information contains warnings about thyroid C-cell tumours, which differs from the US where these medications carry a boxed warning and formal contraindications for certain thyroid conditions
Hydration: GLP-1s can reduce your thirst signal
Using the most recent wave of the GFAPS, we explore consumers expectations about the impact of GLP-1 medications on the food system
Studies have shown an average weight loss of 15% among patients taking GLP-1s, such as semaglutide